Product Images Alunbrig

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Alunbrig NDC 63020-180 by Takeda Pharmaceuticals America, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - alunbrig 01

Chemical Structure - alunbrig 01

PRINCIPAL DISPLAY PANEL - 30 mg Tablet Bottle Label - alunbrig 02

PRINCIPAL DISPLAY PANEL - 30 mg Tablet Bottle Label - alunbrig 02

This appears to be a graph showing the number of patients at risk for two drugs, Brigatinib and Crizotinib, over a period of 12 months. The text also includes the weights of the powders for the drugs. It is likely a medical or pharmaceutical document.*

PRINCIPAL DISPLAY PANEL - 90 mg Tablet Bottle Label - alunbrig 03

PRINCIPAL DISPLAY PANEL - 90 mg Tablet Bottle Label - alunbrig 03

This is a description for a medication named "ALUNBRIG" in tablet form. The medication has a prescribed dose and should be stored at temperatures between 15°C and 30°C. It is important to keep the medication away from children. No further information is available.*

PRINCIPAL DISPLAY PANEL - 180 mg Tablet Bottle Label - alunbrig 04

PRINCIPAL DISPLAY PANEL - 180 mg Tablet Bottle Label - alunbrig 04

This is a description of "ALUNBRIG" tablets containing brigatinib. Each tablet of ALUNBRIG contains 90 mg of brigatinib and the recommended storage temperature is between 20°C to 25°C. It is a prescription medicine and the details should be obtained from the prescribing information. Additionally, it warns to keep the medicine away from children. The NDC number for ALUNBRIG is 6302009030 and 6302003030.*

PRINCIPAL DISPLAY PANEL - Kit Carton - alunbrig 05

PRINCIPAL DISPLAY PANEL - Kit Carton - alunbrig 05

alunbrig 06

alunbrig 06

This is a medication initiation pack for Alunbrig (brigatinib) tablets with different doses of 90mg and 180mg. The usual dosage for the first seven days is one tablet of 90mg orally once per day, then if tolerated, it can be increased to one tablet of 180mg orally once a day. The pack contains 7 tablets of 90mg, 23 tablets of 180mg, and detailed prescribing information. The tablets should be kept away from children and stored between 15 to 30°C.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.